VA
LLY icon

Valmark Advisers’s Eli Lilly LLY Stock Holding History

Valmark Advisers’s Portfolio LLY Stock Details LLY Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$5.31M Buy
5,774
+179
+3% +$181K 0.06% 132
2025
Q4 		$6.01M Sell
5,595
-192
-3% -$184K 0.07% 115
2025
Q3 		$4.42M Buy
5,787
+363
+7% +$270K 0.06% 137
2025
Q2 		$4.23M Sell
5,424
-336
-6% -$261K 0.06% 129
2025
Q1 		$4.76M Sell
5,760
-132
-2% -$110K 0.07% 109
2024
Q4 		$4.55M Sell
5,892
-88
-1% -$72.9K 0.07% 116
2024
Q3 		$5.3M Buy
5,980
+244
+4% +$219K 0.08% 97
2024
Q2 		$5.19M Buy
5,736
+146
+3% +$117K 0.09% 96
2024
Q1 		$4.35M Buy
5,590
+1,047
+23% +$745K 0.08% 103
2023
Q4 		$2.65M Buy
4,543
+69
+2% +$40.3K 0.05% 133
2023
Q3 		$2.4M Buy
4,474
+4
+0.1% +$2.06K 0.05% 127
2023
Q2 		$2.1M Sell
4,470
-157
-3% -$65.8K 0.04% 140
2023
Q1 		$1.59M Sell
4,627
-16
-0.3% -$5.4K 0.03% 170
2022
Q4 		$1.7M Sell
4,643
-773
-14% -$274K 0.04% 157
2022
Q3 		$1.75M Buy
5,416
+155
+3% +$49.1K 0.04% 129
2022
Q2 		$1.71M Sell
5,261
-255
-5% -$76.5K 0.03% 131
2022
Q1 		$1.58M Buy
5,516
+436
+9% +$112K 0.03% 149
2021
Q4 		$1.4M Buy
5,080
+1,463
+40% +$371K 0.02% 154
2021
Q3 		$836K Buy
3,617
+12
+0.3% +$2.96K 0.02% 208
2021
Q2 		$827K Buy
3,605
+45
+1% +$9.04K 0.02% 216
2021
Q1 		$665K Buy
3,560
+416
+13% +$81.4K 0.01% 233
2020
Q4 		$531K Buy
3,144
+204
+7% +$30.5K 0.01% 251
2020
Q3 		$435K Sell
2,940
-19
-0.6% -$2.94K 0.01% 197
2020
Q2 		$486K Buy
2,959
+399
+16% +$61.2K 0.01% 170
2020
Q1 		$355K Buy
2,560
+414
+19% +$56.9K 0.01% 172
2019
Q4 		$282K Buy
2,146
+52
+2% +$6.03K 0.01% 205
2019
Q3 		$234K Buy
2,094
+141
+7% +$15.7K 0.01% 221
2019
Q2 		$216K Sell
1,953
-222
-10% -$26.1K ﹤0.01% 215
2019
Q1 		$282K Buy
2,175
+103
+5% +$12.5K 0.01% 185
2018
Q4 		$240K Buy
+2,072
New +$231K 0.01% 185

Other funds holding LLY

Lilly Endowment
Lilly Endowment Indiananapolis, Indiana $108B AUM 53.87% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
PNC Financial Services Group
PNC Financial Services Group Pittsburgh, Pennsylvania $173B AUM 20.72% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
Capital Research Global Investors
Capital Research Global Investors Los Angeles, California $645B AUM 30.41% 1-Year Est. Return
VPM
Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Capital World Investors
Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return

Valmark Advisers's LLY Position: Q1 2026 in Review

Valmark Advisers increased its Eli Lilly (LLY) stake by 3.2% in Q1 2026, buying an estimated $181K and bringing the position to 5,774 shares worth $5.31M. The position accounts for 0.06% of the portfolio, ranked #132.

Valmark Advisers first reported a position in LLY in Q4 2018 and has held it in 30 quarters since. The position peaked at $6.01M in Q4 2025. 4,354 funds tracked by Wall St. Rank hold LLY as of Q1 2026.

  • Valmark Advisers held 5,774 shares of Eli Lilly worth $5.31M as of Q1 2026.
  • Valmark Advisers bought 179 Eli Lilly shares in Q1 2026, an estimated $181K.
  • Eli Lilly made up 0.06% of Valmark Advisers's portfolio in Q1 2026, its #132 holding.
  • Valmark Advisers first reported a position in Eli Lilly in Q4 2018 and has held it in 30 quarters since.
  • Valmark Advisers's Eli Lilly position peaked at $6.01M in Q4 2025.
  • 4,354 funds tracked by Wall St. Rank held Eli Lilly as of Q1 2026.

Based on Valmark Advisers's 13F filing for Q1 2026, filed 1 May 2026.